The mission of the UWCCC Protocol Review and Monitoring System (PRMS) is to provide the necessaryscientific and regulatory oversight of all clinical research conducted in the UWCCC. The system operates viaone main committee, the Protocol Review and Monitoring Committee (PRMC), which reports to the UWCCCClinical Research Committee chaired by the Associate Director for Clinical Research. The PRMC is chargedwith the responsibility for the scientific and resource review of all new and ongoing clinical research protocols.In addition, the PRMC reviews all cancer related clinical research for compliance with the UW Conflict ofInterest policies and assures an appropriate Data and Safety Monitoring Plan is included in each proposal.The PRMC accomplishes this via the following responsibilities:Review of all new clinical trials for scientific merit, priorities and resource allocation,Prioritization of new clinical trials relative to the clinical disease groups (DOWGs)Prioritization of research relative to the scope of the UWCCC,Review of all ongoing clinical trials for scientific progress,Closing studies for insufficient progress or due to prioritization changes.Through established procedures the PRMC is the oversight mechanism through which all UW cancer-relatedclinical research must flow, thus assuring that all clinical research conducted at the UWCCC is of the highestscientific merit and that UWCCC resources are used efficiently. The PRMS is supervised by the AssociateDirector for Clinical Research (H. Bailey) and the PRMC is chaired by J. Cleary, Associate Professor ofMedicine and co-chaired by K. Kim, Professor of Biostatistics and Medical Informatics, researchers each with>15 years of clinical research performance and monitoring.
Showing the most recent 10 out of 1528 publications
